Frederick, MD, United States of America

Sergey G Tarasov

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Sergey G Tarasov

Introduction

Sergey G Tarasov is a notable inventor based in Frederick, MD (US), recognized for his significant contributions to the field of biotechnology. With a total of 3 patents, he has made strides in developing innovative solutions for medical applications.

Latest Patents

One of his latest patents is a peptide-based STAT inhibitor. This invention involves a peptide or peptidomimetic that comprises the amino acid sequence of the second helix of a STAT protein, or a variant of such sequence. The peptide or peptidomimetic consists of about 40 or fewer amino acids and binds to a STAT protein. It also includes methods for inhibiting a STAT protein in a cell and treating or preventing diseases associated with STAT overexpression in a host. Another significant patent is related to self-assembling nanoparticles composed of transmembrane peptides. This invention provides a method for handling a hydrophobic agent by combining it with an isolated peptide that is a structural analog of a transmembrane domain of an integral membrane protein. The method allows the peptide to self-assemble into nanoparticles that comprise the hydrophobic agent, facilitating specific intra-tumor delivery of anti-cancer drugs.

Career Highlights

Throughout his career, Sergey has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His work has contributed to advancements in medical research and therapeutic applications.

Collaborations

Sergey has collaborated with notable individuals in his field, including Nadya Tarasova and Vadim Gaponenko. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Sergey G Tarasov's innovative work in biotechnology, particularly in the development of peptide-based inhibitors and self-assembling nanoparticles, showcases his commitment to advancing medical science. His contributions continue to have a significant impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…